ea0046p7 | (1) | UKINETS2016
Mateo-Vito Ivy
, Amlani Ashik
, Leshen Rebelidad
, Mcmeekin Helena
, Davis Neil
, Navalkissoor Shaunak
Background: NET-related symptoms such as flushing and diarrhoeas as well as disease related worries reduce quality of life in patients with neuroendocrine tumours (NETs). Peptide receptor radionuclide therapy (PRRT) is an established treatment in NETs and has been shown to prolong survival. However quality of life data post PRRT is lacking.Aim: To evaluate the symptoms prevalence, intensity and their relation to quality of life in patients receiving PRRT...